Treatment of paediatric cholestasis due to canalicular transport defects: Yet another step forward

Gut

Volumn 64, Issue 1, 2015, Pages 6-8

  Marin, Jose J G ^a   Houwen, Roderick H J ^b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ATP8B1 PROTEIN; BILE ACID; BILE SALT EXPORT PUMP; COLESTYRAMINE; MULTIDRUG RESISTANCE PROTEIN 3; RIFAMPICIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; MULTIDRUG RESISTANCE PROTEIN;

ACTIVE TRANSPORT; BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS TYPE 1; BILE FLOW; CHOLESTASIS; END STAGE LIVER DISEASE; GENE MUTATION; HETEROZYGOTE; HUMAN; INTRAHEPATIC BILE DUCT; LIVER TRANSPLANTATION; NOTE; PHARMACOGENETICS; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 1; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3; PRURITUS; REMISSION; CHOLESTASIS, INTRAHEPATIC; DEFICIENCY; FEMALE; GENETICS; MALE; MISSENSE MUTATION; PHYSIOLOGY;

CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; P-GLYCOPROTEINS; URSODEOXYCHOLIC ACID;

EID: 84919767203     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307014     Document Type: Note

References (10)

1. Stapelbroek JM, van Erpecum KJ, Klomp LW, et al. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010; 52: 258-71.
2. Gordo-Gilart R, Sara Andueza S, Hierro L, et al. Functional analysis of ABCB4 mutations relates clinical outcomes of Progressive Familial Intrahepatic Cholestasis type 3 to the degree of MDR3 floppase activity. Gut 2015; 64: 147-55.
3. Monte MJ, Marin JJ, Antelo A, et al. Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 2009; 15: 804-16.
4. Hayashi H, Takada T, Suzuki H, et al. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology 2005; 41: 916-24.
5. Liu LY, Wang ZL, Wang XH, et al. ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low gamma glutamyltransferase. Liver Int 2010; 30: 809-15.
6. Groen A, Romero MR, Kunne C, et al. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. Gastroenterology 2011; 141: 1927-37. e1-4.
7. Oude Elferink RP, Beuers U. Targeting the ABCB4 gene to control cholesterol homeostasis. Expert Opin Ther Targets 2011; 15: 1173-82.
8. Lammert F, Wang DQ, Hillebrandt S, et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/-mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004; 39: 117-28.
9. Colombo C, Vajro P, Degiorgio D, et al. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr 2011; 52: 73-83.
10. Jacquemin E, De Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120: 1448-58.